|Last Price$167.20||Day Change (%)0.83%|
|Open Price$166.70||Day Change ($)1.38|
|Day Range164.94–167.67||52-Week Range100.89–185.43|
As of Wed 10/01/2014 04:11 PM EST | USD
Improved Survival Observed in Pediatric Patients with Severe Hypophosphatasia (HPP) Who Were Treated with Investigational Asfotase Alfa for Up to Five Years
NICE Recommends Commissioning of Eculizumab (Soliris®) for All Patients with aHUS in England
We crunch the numbers to see which stocks are most widely held among analyst-recommended large-cap funds.
Ownership data provide a look at who else owns the company.
Standing out in a good year for stocks.
Week ending Nov. 10: Investors remain optimistic about direction of economy.
Buying a country or sector fund isn't as easy as it seems.